These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27045377)

  • 1. The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.
    Mehraj V; Jenabian MA; Ponte R; Lebouché B; Costiniuk C; Thomas R; Baril JG; LeBlanc R; Cox J; Tremblay C; Routy JP;
    AIDS; 2016 Jun; 30(10):1617-27. PubMed ID: 27045377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
    Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
    J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus.
    Isnard S; Ramendra R; Dupuy FP; Lin J; Fombuena B; Kokinov N; Kema I; Jenabian MA; Lebouché B; Costiniuk CT; Ancuta P; Bernard NF; Silverman MS; Lakatos PL; Durand M; Tremblay C; Routy JP;
    J Infect Dis; 2020 Jan; 221(1):110-121. PubMed ID: 31504638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
    Clayton KL; Douglas-Vail MB; Nur-ur Rahman AK; Medcalf KE; Xie IY; Chew GM; Tandon R; Lanteri MC; Norris PJ; Deeks SG; Ndhlovu LC; Ostrowski MA
    J Virol; 2015 Apr; 89(7):3723-36. PubMed ID: 25609823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
    Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
    Front Immunol; 2021; 12():688886. PubMed ID: 34135912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
    He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
    Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
    Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
    HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Expression of sST2 in Early HIV Infected Patients Attenuated the IL-33 Induced T Cell Responses.
    Wu X; Li Y; Song CB; Chen YL; Fu YJ; Jiang YJ; Ding HB; Shang H; Zhang ZN
    Front Immunol; 2018; 9():2850. PubMed ID: 30564243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
    Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut epithelial barrier and systemic inflammation during chronic HIV infection.
    Somsouk M; Estes JD; Deleage C; Dunham RM; Albright R; Inadomi JM; Martin JN; Deeks SG; McCune JM; Hunt PW
    AIDS; 2015 Jan; 29(1):43-51. PubMed ID: 25387317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
    Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
    Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
    Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
    AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.
    Kieler M; Unseld M; Wojta J; Kaider A; Bianconi D; Demyanets S; Prager GW
    Med Oncol; 2018 Nov; 36(1):1. PubMed ID: 30426271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
    Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
    Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
    Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of IL-33 in immune thrombocytopenia.
    Li PP; Zhang XM; Yuan D; Liu X; Li Y; Shan NN
    Int Immunopharmacol; 2015 Sep; 28(1):420-4. PubMed ID: 26164496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.